Allergologie-immunologie: Facteurs d’échec du traitement de l’asthme et nouveautés thérapeutiques [Risk of treatment failure and therapeutic novelties in asthma]

Details

Serval ID
serval:BIB_0C52767F8451
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Allergologie-immunologie: Facteurs d’échec du traitement de l’asthme et nouveautés thérapeutiques [Risk of treatment failure and therapeutic novelties in asthma]
Journal
Revue medicale suisse
Author(s)
Horisberger A., Mahdi Aljedani R., Spertini F., Ribi C.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
09/01/2019
Peer-reviewed
Oui
Volume
15
Number
N° 632-633
Pages
23-26
Language
french
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Asthma is a chronic disease that is still frequently poorly controlled, despite recent advances in understanding its pathophysiology. Poor compliance and ineffective inhalation technique remain the main causes of treatment failure. The comorbidities associated with asthma, such as obesity and chronic rhinosinusitis, are other elements to consider in the management of patients. Biological treatments targeting inflammation mediators show encouraging results in recurrent asthma exacerbations despite optimal management. However, their benefit remains limited to certain patients, thus requiring the study of predictive biomarkers to better delineate their indication.
Keywords
Anti-Asthmatic Agents, Asthma/drug therapy, Humans, Treatment Failure
Pubmed
Create date
10/02/2019 16:31
Last modification date
20/08/2019 13:33
Usage data